Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.

导出原文传递

翻译打印收藏纠错

作者： Alexandr,Poprach ^[1] ; Igor,Kiss ^[1] ; Michal,Stanik ^[2] ; Tamara,Barusova ^[3] ; Lenka,Pospisilova ^[3] ; Ondrej,Fiala ^[4] ; Jindrich,Kopecky ^[5] ; Igor,Richter ^[6] ; Bohuslav,Melichar ^[7] ; Hana,Studentova ^[8] ; Radek,Lakomy ^[8] ; Milos,Holanek ^[1] ; Aneta,Rozsypalova ^[1] ; Anezka,Zemanková ^[9] ; Marek,Svoboda ^[8] ; Tomas,Buchler ^[1]

作者单位： Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic. ^[1] Department of Urologic Oncology, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic. ^[2] Institute of Biostatistics and Analyses Brno, Brno, Czech Republic. ^[3] Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. ^[4] Faculty of Medicine in Pilsen, Biomedical Centre, Charles University, Pilsen, Czech Republic. ^[5] University Hospital in Hradec Králové, Hradec Králové, Czech Republic. ^[6] Department of Oncology, Liberec Regional Hospital, Liberec, Czech Republic. ^[7] Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. ^[8] Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic. ^[9] Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06, Prague, Czech Republic. tomas.buchler@fnmotol.cz. ^[10]

主题词人类(Humans);癌, 肾细胞(Carcinoma, Renal Cell);肾肿瘤(Kidney Neoplasms);回顾性研究(Retrospective Studies);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);免疫疗法(Immunotherapy)

DOI 10.1007/s11523-023-01013-0

PMID 37957520

发布时间 2023-11-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交